Fingerprint
Dive into the research topics of 'In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia
Paul La Rosée, Kara Johnson, Michael E. O'Dwyer, Brian J. Druker
Research output: Contribution to journal › Article › peer-review
89
Scopus
citations